Afluria

BIOLOGICAL2 trials

Sponsors

University of Massachusetts, Worcester, Protein Sciences Corporation

Conditions

Immune ResponseInfluenza

Phase 3

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

CompletedNCT01825200

Protein Sciences CorporationInfluenza

Start: 2013-03-31End: 2013-05-31Updated: 2015-02-18

Unknown Phase

Immune Responses Induced by Different Licensed Influenza Vaccines

CompletedNCT00902278

University of Massachusetts, WorcesterImmune Response

Start: 2008-10-31End: 2016-04-30Updated: 2017-11-20

Related Papers

Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.

2015-11-0121 citations